« Back
Home /
LY518674

LY518674

Item no.	TMO-T15821-10mg
Manufacturer	TargetMol
CASRN	425671-29-0
Amount	10 mg
Quantity options	100 mg 100 mg 1 mL x 10 mM (in DMSO) 1 mL x 10 mM (in DMSO) 10 mg 10 mg 1 mg 1 mg 1 mL 200 mg 25 mg 25 mg 2 mg 50 mg 50 mg
Category	Oncology Cell Biology Cell Status Apoptosis Reagents & Chemicals Molecules By Organ Uterine, Ovarian & Cervical Cancer
Type	Molecules
Specific against	other
Smiles	Cc1ccc(Cn2[nH]c(CCCc3ccc(OC(C)(C)C(O)=O)cc3)nc2=O)cc1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	LY-674
Shipping Condition	Cool pack
Available
Manufacturer - Targets	PPAR
Shipping Temperature	Cool pack
Storage Conditions	-20°C
Molecular Weight	409, 48
Description	LY518674 (LY-674) decreases triglycerides and increases HDL-C and is used for the treatment of atherosclerosis. LY518674 is an effective and selective PPARα agonist (EC50: 42 nM for human PPARα).
Pathways	DNA Damage/DNA Repair\|\|\|Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T15821-10mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 10 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question